Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1996-12-11
1998-06-16
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514171, 514553, 514597, A61K 3166, A61K 3156, A61K 31185, A61K 3117
Patent
active
057671109
ABSTRACT:
Suramin in combination with a vinca alkaloid or estramustine is synergistic for treating cancer.
REFERENCES:
patent: 5158940 (1992-10-01), LaRocca et al.
patent: 5385936 (1995-01-01), Flack et al.
Studies of Suramin (Antrypol: Bayer 205), vol. 40, 1946, Dewey et al., pp. 119-124.
Journal of Clinical Oncology, vol. 7, No. 4, 1989, Stein et al., pp. 499-508.
Journal of the National Cancer Institute, vol. 86, No. 20, 1994, Chou et al., pp. 1517-1524.
Synergism and Antagonism in Chemotherapy, Chapter 6, 1991, Chou et al., pp. 223-241.
Journal of the National Cancer Institute, vol. 82, No. 14, 1990, Fruehauf et al., pp. 1206-1209.
Proceedings of the American Association for Cancer Research, vol. 35, 1994, Rago et al., p. 329, abstract 1956.
Molecular Pharmacology, vol. 33, No. 4, 1988, Zamora et al., pp. 454-462.
Carter et al, Chemotherapy of Lawler, 2nd ed, John Wiley & Sons, N.Y., N.Y., 1981 p. 126.
Klohs Wayne Daniel
Kowal Charles Dale
Ashbrook Charles W.
Goldberg Jerome D.
Warner-Lambert & Company
LandOfFree
Combination chemotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination chemotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination chemotherapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726217